[冠状动脉扩张剂3 - （β - 二乙氨基乙基）-4 - 甲基-7 - 乙氧甲氧基-2 - 氧代-（1,2 - 苯并二氢吡喃）盐酸盐的生化药理学研究。1. 血浆、组织和尿液中该物质及其代谢产物的测定方法] - Suppr | 超能文献

[Biochemical pharmacological studies of the coronary dilator 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride. 1. Methods for determination of the substance and its metabolites in plasma, tissues and urine].

作者信息

Klarwein M, Nitz R E

出版信息

Arzneimittelforschung. 1965 May;15(5):555-8.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Biochemical pharmacological studies of the coronary dilator 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride. 1. Methods for determination of the substance and its metabolites in plasma, tissues and urine].[冠状动脉扩张剂3 - （β - 二乙氨基乙基）-4 - 甲基-7 - 乙氧甲氧基-2 - 氧代-（1,2 - 苯并二氢吡喃）盐酸盐的生化药理学研究。1. 血浆、组织和尿液中该物质及其代谢产物的测定方法]

Arzneimittelforschung. 1965 May;15(5):555-8.

2

Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).3-（β-二乙氨基乙基）-4-甲基-7-乙氧羰基甲氧基-2-氧代-（1,2-苯并二氢吡喃）盐酸盐（英坦生，A-27053）对全身和冠状动脉血流动力学的影响

Vasc Dis. 1967 Jun;4(3):183-90.

3

Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).3-（β-二乙氨基乙基）-4-甲基-7-乙氧羰基甲氧基-2-氧代-（1,2-苯并二氢吡喃）盐酸盐（英坦生，A-27053）对全身和冠状动脉血流动力学的影响

Arch Int Pharmacodyn Ther. 1969 Mar;178(1):99-103.

4

[Effects of new vasoactive drug, 3(beta-diethylamino-ethyl)-4-methyl-7-(carbethoxy-methoxy)-2-oxy-1,2-chromen HC1 (Intensain) on the coronary circulation in dogs].新型血管活性药物3-(β-二乙氨基乙基)-4-甲基-7-(乙氧羰基甲氧基)-2-氧代-1,2-色满盐酸盐（英坦生）对犬冠脉循环的影响

Minerva Cardioangiol. 1967 Nov;15(11):722-4.

5

[Pharmacodynamic studies after short- and long-term treatment with radioactively labelled 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-2-oxo-(1,2-chromene)-hydrochloride in animal experiments].[放射性标记的3-（β-二乙氨基乙基）-4-甲基-7-乙氧羰基-2-氧代-（1,2-苯并二氢吡喃）盐酸盐在动物实验中的短期和长期治疗后的药效学研究]

Arzneimittelforschung. 1972 Aug;22(8):1242-50.

6

[Pharmacodynamic effect on coronary blood circulation and metabolism of the human heart. Studies with 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromen)-hydrochloride].[对人体心脏冠状动脉血液循环和代谢的药效学作用。3-（β-二乙氨基乙基）-4-甲基-7-乙氧甲氧基-2-氧代-（1,2-色烯）盐酸盐的研究]

Klin Wochenschr. 1967 Apr 1;45(7):333-53. doi: 10.1007/BF01738741.

7

Disposition and metabolism of fenbufen in several laboratory animals.非布芬在几种实验动物中的处置与代谢。

Arzneimittelforschung. 1980;30(4A):707-15.

8

[Pharmacodynamic aspects of a new coronary dilator: (3,4,5, trimethoxycinnamoil)-1 (ethylacetate)-4-piperazine maleate (6753)].一种新型冠状动脉扩张剂的药效学方面：（3,4,5-三甲氧基肉桂酰基）-1-（乙酸乙酯）-4-哌嗪马来酸盐（6753）

Boll Soc Ital Cardiol. 1971;16(9):523-30.

9

[Protracted coronary vasodilator effect of 3-(2-diethylaminoethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-1.2-chromene].

Med Welt. 1963 Apr 27;17:976-9.

10

Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.具有特定抗毒蕈碱特性的新型解痉剂西科韦林的药理学。第2部分：一般药理学特性。

Arzneimittelforschung. 1980;30(9):1526-34.

引用本文的文献

1

Energy-dependent extrusion of cyclic 3',5'-adenosine-monophosphate. A drug-sensitive regulatory mechanism for the intracellular nucleotide concentration in rat erythrocytes.环磷酸腺苷的能量依赖性外排。大鼠红细胞内核苷酸浓度的药物敏感调节机制。

Naunyn Schmiedebergs Arch Pharmacol. 1982 Dec;321(4):239-46. doi: 10.1007/BF00498507.

2

[Species differences in the hydrolysis of dexamethasone-21-isonicotinate].[地塞米松-21-异烟酸酯水解的种属差异]

Klin Wochenschr. 1972 Jul 1;50(13):665-6. doi: 10.1007/BF01487085.

3

New coronary active benzopyranone derivatives.新型冠状活性苯并吡喃酮衍生物

Naturwissenschaften. 1977 Apr;64(4):225. doi: 10.1007/BF00449979.